Published in Sci Rep on December 23, 2016
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
Metals, toxicity and oxidative stress. Curr Med Chem (2005) 7.48
Genomic scale profiling of nutrient and trace elements in Arabidopsis thaliana. Nat Biotechnol (2003) 4.20
Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung (1971) 3.71
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A (1997) 3.47
Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol (1988) 2.55
Untangling amyloid-β, tau, and metals in Alzheimer's disease. ACS Chem Biol (2013) 1.82
The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron (2014) 1.59
Transition metal abnormalities in progressive dementias. Biometals (2011) 1.51
The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron (2014) 1.35
Selenoproteins: molecular pathways and physiological roles. Physiol Rev (2014) 1.34
Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci (2014) 1.30
Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem Int (2012) 1.29
Ionomics: studying the social network of mineral nutrients. Curr Opin Plant Biol (2009) 1.27
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc Natl Acad Sci U S A (2010) 1.24
Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat. Biol Trace Elem Res (1997) 1.18
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Drug Deliv Rev (2008) 1.18
Selenium biochemistry and its role for human health. Metallomics (2014) 1.13
Metallostasis in Alzheimer's disease. Free Radic Biol Med (2012) 1.13
The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review. Curr Environ Health Rep (2014) 1.11
Successful therapies for Alzheimer's disease: why so many in animal models and none in humans? Front Pharmacol (2014) 1.10
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci (2015) 1.07
The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact (2010) 1.04
Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J Trace Elem Med Biol (2010) 1.02
Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front Cell Neurosci (2014) 1.01
Transient dynamics of Aβ contribute to toxicity in Alzheimer's disease. Cell Mol Life Sci (2014) 1.01
Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis (2008) 1.00
Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect (1991) 1.00
Selenium and Alzheimer's disease: a systematic review. J Alzheimers Dis (2011) 0.99
Network analysis: tackling complex data to study plant metabolism. Trends Biotechnol (2012) 0.95
Does inorganic mercury play a role in Alzheimer's disease? A systematic review and an integrated molecular mechanism. J Alzheimers Dis (2010) 0.95
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model. J Clin Neurosci (2010) 0.95
Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks. Sci Rep (2013) 0.94
Manganese stimulates calcium flux through the mitochondrial uniporter. Biochim Biophys Acta (1985) 0.93
EdgeMarker: Identifying differentially correlated molecule pairs as edge-biomarkers. J Theor Biol (2014) 0.90
Oxidative stress in Alzheimer's disease. Neurosci Bull (2014) 0.90
Multicopper oxidase-1 is a ferroxidase essential for iron homeostasis in Drosophila melanogaster. Proc Natl Acad Sci U S A (2012) 0.89
β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease. Front Aging Neurosci (2014) 0.89
Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders. Neurochem Int (2015) 0.88
Insulin resistance in Alzheimer's disease. Neurobiol Dis (2014) 0.88
Cu(2+) affects amyloid-β (1-42) aggregation by increasing peptide-peptide binding forces. PLoS One (2013) 0.88
Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model. Mol Brain (2014) 0.88
Towards a unified vision of copper involvement in Alzheimer's disease: a review connecting basic, experimental, and clinical research. J Alzheimers Dis (2015) 0.88
Nutritional status of selenium in Alzheimer's disease patients. Br J Nutr (2009) 0.87
Selenium-containing amino acids as direct and indirect antioxidants. IUBMB Life (2012) 0.86
Genome-wide RNAi ionomics screen reveals new genes and regulation of human trace element metabolism. Nat Commun (2014) 0.86
Zinc and its effects on oxidative stress in Alzheimer's disease. Neurol Sci (2014) 0.85
Selenium and selenoprotein function in brain disorders. IUBMB Life (2014) 0.85
Tau acts as a mediator for Alzheimer's disease-related synaptic deficits. Eur J Neurosci (2014) 0.85
Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies. Surg Neurol Int (2015) 0.85
Biometals and their therapeutic implications in Alzheimer's disease. Neurotherapeutics (2015) 0.85
Multi-elemental profiling and chemo-metric validation revealed nutritional qualities of Zingiber officinale. Ecotoxicol Environ Saf (2014) 0.84
Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective. Adv Med Sci (2014) 0.84
Copper chelator induced efficient episodic memory recovery in a non-transgenic Alzheimer's mouse model. PLoS One (2012) 0.83
Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms. Front Endocrinol (Lausanne) (2014) 0.83
Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease. Neurobiol Aging (2014) 0.82
Detecting amyloid-β plaques in Alzheimer's disease. Methods Mol Biol (2011) 0.81
Dynamics and partitioning of the ionome in seeds and germinating seedlings of winter oilseed rape. Metallomics (2013) 0.81
Effect of selenium supplementation with sodium selenite and selenium nanoparticles on iron homeostasis and transferrin gene expression in sheep: a preliminary study. Res Vet Sci (2011) 0.80
Role of metal ions in the cognitive decline of Down syndrome. Front Aging Neurosci (2014) 0.80
Mass spectrometry-based metabolomic profiling identifies alterations in salivary redox status and fatty acid metabolism in response to inflammation and oxidative stress in periodontal disease. Free Radic Biol Med (2014) 0.80
Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity. Neurochem Int (2014) 0.80
Heavy metals toxicity: effect of cadmium ions on amyloid beta protein 1-42. Possible implications for Alzheimer's disease. Biometals (2014) 0.80
Homeostasis of metals in the progression of Alzheimer's disease. Biometals (2014) 0.79
Organization of the Mammalian Ionome According to Organ Origin, Lineage Specialization, and Longevity. Cell Rep (2015) 0.79
Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol Sci (2014) 0.79
High manganese, a risk for Alzheimer's disease: high manganese induces amyloid-β related cognitive impairment. J Alzheimers Dis (2014) 0.78
The role of zinc in the pathogenesis and treatment of central nervous system (CNS) diseases. Implications of zinc homeostasis for proper CNS function. Acta Pol Pharm (2014) 0.78
Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's model. PLoS One (2014) 0.78
Environmental lead-210 and bismuth-210 accrue selectively in the brain proteins in Alzheimer disease and brain lipids in Parkinson disease. Alzheimer Dis Assoc Disord (2001) 0.78
Effects of selenium supplementation on selenium status of farmed fallow deer in outdoor pens. J Trace Elem Med Biol (2015) 0.77
Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models. Neurobiol Dis (2011) 0.77
A possible significant role of zinc and GPR39 zinc sensing receptor in Alzheimer disease and epilepsy. Biomed Pharmacother (2016) 0.77
Selenium regulates expression in rat liver of genes for proteins involved in iron metabolism. Biol Trace Elem Res (2000) 0.77
Metabolic differences and similarities of selenium in blood and brain of the rat following the administration of different selenium compounds. Biol Trace Elem Res (1992) 0.76
Phosphoproteomic profiling of selenate-treated Alzheimer's disease model cells. PLoS One (2014) 0.76
Effect of intermittent supplementation with selenate on selenium status of rats fed selenium-deficient diet. J Nutr Sci Vitaminol (Tokyo) (2005) 0.76
Magnesium Status in Alzheimer's Disease: A Systematic Review. Am J Alzheimers Dis Other Demen (2015) 0.76
Elevated amyloid-β plaque deposition in dietary selenium-deficient Tg2576 transgenic mice. Metallomics (2013) 0.75
Bismuth Toxicity Masquerading as Alzheimer's Dementia. J Alzheimers Dis (1998) 0.75